Price transparency rule isn’t preventing patients from overpaying thousands for labs & tests

(By Katie Adams for Becker’s Hospital Review)

CMS’ price transparency rule aims to save Americans money by allowing them to price shop for healthcare services, but it’s still common for patients to overpay for their tests and lab work, sometimes by thousands of dollars, according to research released June 8 by pharmacy discount company GoodRx.  Continue reading the article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org